Skip to main content
. Author manuscript; available in PMC: 2024 Jun 1.
Published in final edited form as: South Med J. 2023 Jun;116(6):455–463. doi: 10.14423/SMJ.0000000000001564

Table 1.

Description of PrEP study cohort by state

Medicaid expansion state

State A State B State C State D State E State F

No Yes Yes No No No

Characteristic N % N % N % N N % N %
Age group, y
16–19 28 20.4 <11 37 8.4 56 31.1 11 14.7 16 20.5
20–24 16 11.7 12 15.0 68 15.5 24 13.3 <11 14 17.9
25–29 23 16.8 14 17.5 111 25.2 22 12.2 17 22.7 12 15.4
30–34 27 19.7 13 16.3 58 13.2 21 11.6 <11 <11
35–39 12 8.8 13 16.3 50 11.4 15 8.3 12 16.0 <11
40–64 31 22.6 24 30.0 116 26.4 42 23.3 16 21.3 22 28.2
Race/ethnicity
Non-Hispanic White 32 23.4 47 58.8 148 33.6 72 40.0 26 34.7 22 28.2
Non-Hispanic Black 75 54.7 <11 137 31.1 83 46.1 40 53.3 23 29.5
Hispanic <11 <11 27 6.1 <11 <11 <11
Other 30 21.9 23 28.7 128 29.1 20 11.1 <11 33 42.3
Sex
Female 100 73.0 9 11.3 98 22.3 117 65.0 54 72.0 35 44.9
Male 37 27.0 71 88.8 342 77.7 63 35.0 21 28.0 43 55.1
Eligibility group  
Children, 16–19 y 28 20.4 <11 37 8.4 56 31.1 11 14.7 16 20.5
Disabled adults 46 33.6 <11 32 7.3 48 26.6 21 28.0 32 41.0
Medicaid expansion adults 0 0.0 70 87.5 344 78.2 0 0.0 0 0.0 0 0.0
Nondisabled, nonexpansion adults 63 46.0 <11 27 6.1 70 38.8 43 57.3 30 38.5
Living area  
Urban 114 83.2 58 72.5 399 90.7 144 80.0 57 76.0 65 83.3
Rural 21 15.3 22 27.5 38 8.6 36 20.0 17 22.7 <11
Total PrEP, n 137 80 440 180 75 78
Total PrEP/100,000 Medicaid enrollees 32.2 9.1 51.3 18.2 11.0 10.5

PrEP, preexposure prophylaxis.